RSS   Newsletter   Contact   Advertise with us
Post Online Media

IBT appoints new CFO

IBTInfant Bacterial Therapeutics AB ("IBT"), a subsidiary of BioGaia AB, announces the appointment of Daniel Mackey as chief financial officer from January 2017.
Mr. Mackey has 20 years experience from diverse U.S. and international management positions in finance and accounting with Investors Bank & Trust Co., Nordea Investment Management AB and Nordea Bank AB.

He is replacing Michael Owens in this role.

Mr. Owens will continue as financial controller of the company.




We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy